{"title":"造血干细胞移植","authors":"","doi":"10.1093/med/9780198779186.003.0015","DOIUrl":null,"url":null,"abstract":"Haemopoietic stem cell transplantation (HSCT) is used to treat a wide variety of haematological and certain solid malignancies, as well as several other serious haematological, immunological, auto-immune and metabolic diseases. This chapter describes the aims and principals of, and indications for, HSCT. The recipient and donor preparation for HSCT, and recipient conditioning treatment including graft-versus-host disease (GvHD) prophylaxis, are outlined. The acute and late complications of HSCT, including GvHD, are described.","PeriodicalId":347115,"journal":{"name":"Paediatric Haemotology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Haemopoietic stem cell transplantation\",\"authors\":\"\",\"doi\":\"10.1093/med/9780198779186.003.0015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Haemopoietic stem cell transplantation (HSCT) is used to treat a wide variety of haematological and certain solid malignancies, as well as several other serious haematological, immunological, auto-immune and metabolic diseases. This chapter describes the aims and principals of, and indications for, HSCT. The recipient and donor preparation for HSCT, and recipient conditioning treatment including graft-versus-host disease (GvHD) prophylaxis, are outlined. The acute and late complications of HSCT, including GvHD, are described.\",\"PeriodicalId\":347115,\"journal\":{\"name\":\"Paediatric Haemotology and Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Paediatric Haemotology and Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/med/9780198779186.003.0015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatric Haemotology and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198779186.003.0015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Haemopoietic stem cell transplantation (HSCT) is used to treat a wide variety of haematological and certain solid malignancies, as well as several other serious haematological, immunological, auto-immune and metabolic diseases. This chapter describes the aims and principals of, and indications for, HSCT. The recipient and donor preparation for HSCT, and recipient conditioning treatment including graft-versus-host disease (GvHD) prophylaxis, are outlined. The acute and late complications of HSCT, including GvHD, are described.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
